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Abstract
Adhesion is a primordial cell function that, among others, regulates inflammation, metastasis, and tissue repair. To
 .understand how these events could be affected by photodynamic therapy PDT , we studied the effects of PDT on human
 .foreskin fibroblast HFF adhesion to bovine collagen type I, human vitronectin or fibronectin. PDT, using benzoporphyrin
 .derivative monoacid ring A verteporfin as the photosensitizer, inhibited cell adhesion in a drug dose-dependent manner,
with no significant difference among matrices. The drug dose that killed 90% of cells within 20 h post-treatment inhibited
HFF adhesion by 55%–68%. However, 45 min following PDT, a time period corresponding to that of the adhesion assay,
HFF membrane integrity remained unaltered. In addition, cell surface expression of integrins was not modified for at least
2 h following PDT. Western blots of cell lysates, using the anti-phosphotyrosine 4G10 monoclonal antibody, revealed that
PDT prevented the adhesion-induced phosphorylation of 110–130 kDa proteins. Immunoblots of cell lysates immunoprecip-
itated with antibodies to focal adhesion kinase suggested that its phosphorylation was suppressed by PDT. These results
demonstrate that PDT inhibits cell adhesion and affects integrin signalling without modifying cell membrane integrity or
integrin expression. q 1997 Elsevier Science B.V.
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Abbreviations: BPD-MA, benzoporphyrin derivative monoacid
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protein tyrosine kinase; SDS, sodium dodecyl sulfate; VN, hu-
man vitronectin
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1. Introduction
 .Photodynamic therapy PDT , a light treatment of
tissue that has accumulated a photosensitizer, has
gained international market approvals for various on-
cological indications. More recently, PDT is being
tested as a therapy in non-oncological diseases in-
cluding macular degeneration, psoriasis, and rheuma-
w xtoid arthritis 1 .
The molecular principle of PDT consists of the
light-induced, photosensitizer-mediated formation of
reactive oxygen species that disarrange cell compo-
w xnents 2,3 . Intensive studies on the aftermath of PDT
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on cell functions revealed that PDT induced cytoplas-
w xmic calcium release 4 , activation of heat-shock pro-
w x w xteins 5 and mitogen-activated protein kinases 6 ,
w x  w x.and apoptosis 7 for review, see 8–10 . However,
little attention has been given to the effects of PDT
on cell adhesion properties, in spite of the promiscu-
ous role that cell adhesion plays in the natural history
of diseases targeted by, or events associated with,
PDT such as metastasis, inflammation, and tissue
repair.
Light exposure caused polymorphonuclear leuko-
cytes loaded with the first generation photosensitizer
PHOTOFRINw porfimer sodium to adhere to the
w xwall of normal vessels 11 but not to those of tumor
w xcapillaries 12 . However, exposure of human neu-
trophils to pheophorbide a and ambient light elicited
a decrease in binding properties of intercellular adhe-
w xsion molecule-1 and integrin a b 13 . Recent re-L 2
ports suggest that, following in vitro PDT, adhesive-
w xness of malignant cells to endothelial cells 14 , as
well as their capability to invade basement membrane
w x15 , declined. While investigating the mechanisms
by which PDT inhibited vascular intimal hyperplasia,
Adili et al. noted that PDT of extracellular matrices
impaired smooth muscle cell, but not endothelial cell,
w xattachment 16 .
Cell adhesion includes both cell–cell and cell-ex-
 .tracellular matrix ECM adhesion processes. In this
work, the effects of PDT on the latter type of interac-
tions were investigated using fibroblasts and the ex-
tracellular glycoproteins bovine collagen type I
 .  .COL , human vitronectin VN , and human fi-
 .bronectin FN . Their receptors are transmembrane
ab heterodimers, called integrins because of their
ability to link the ECM mesh with the cytoskeleton
w x17 . Integrins also are one of the classes of molecules
that mediate cell–cell attachment. Cell adhesion on
ECM is driven by the integrins, which recognize an
Arg–Gly–Asp sequence on the matrix glycoprotein.
Each integrin can bind different matrices, and one
particular matrix can interact with cells through sev-
w xeral types of integrins 17 . Following the integrin-
mediated attachment to the substratum, cells alter
their shape and spread by redeployment of actin
stress fibers. Ligand occupancy provokes clustering
of adjacent integrins on the cell surface, which trig-
gers the assembly of focal adhesions, through the
activation of local signalling pathways and the con-
fined rearrangement of associated cytoplasmic plaque
w xproteins and actin filaments 18 . Unlike the growth
factor receptors, the cytoplasmic domains of integrins
do not possess kinase activity. However, protein tyro-
 .sine kinases PTK located in focal adhesions, in
 .particular focal adhesion kinase FAK , are believed
w xto relay the integrin signal within the cytoplasm 19 .
The present work showed that PDT using benzo-
 .porphyrin derivative monoacid ring A verteporfin
 .BPD-MA inhibited fibroblast adhesion in a drug
dose-dependent manner, with no significant differ-
ence among matrices. PDT-related loss of adhesive-
ness was not attributable to an impairment of mem-
brane integrity or integrin expression. In addition, the
suppression of adhesion-induced phosphorylation of
FAK illustrated the fact that PDT affected integrin
signalling.
2. Materials and methods
2.1. Cell culture
 .Human foreskin fibroblasts HFF originated from
a primary culture of tissue from Vancouver Children’s
Hospital. Cells were subcultured from passage 5 to
15 in DMEM supplemented with 2 mM L-glutamine,
100 Urml penicillin, 100 mgrml streptomycin, 1 mM
sodium pyruvate, and 10% heat inactivated fetal calf
serum Gibco LifeTechnologies, Burlington, ON,
.Canada . Medium was buffered with 20 mM Hepes
 .Sigma, St-Louis, MO . Cells were passaged using
0.05% trypsin, 0.53 mM EDTA Gibco LifeTech-
.  .nologies solution in phosphate buffered saline PBS .
2.2. Reagents
 .Crystal violet, sodium dodecyl sulfate SDS ,
 .bovine serum albumin type V BSA , propidium
 .iodide PI , cycloheximide, Tris, glycerol, phenyl-
methylsulfonylfluoride, and mouse IgG1 were ob-
tained from Sigma. COL was a gift from Dr. Dave
w xHunt 20 . VN, FN, and rat monoclonal antibody anti
 .human integrin a mAb 16 were purchased from5
 .Collaborative Biomedical Products, Bedford, MA .
Aprotinin and sodium orthovanadate were bought
 .from Calbiochem San Diego, CA and Aldrich
 .Milwaukee, WI , respectively. Rat IgG , trypsin in-2
hibitor, and mouse monoclonal antibodies to human
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 .  .  .integrin b P4C10 , a b P1F6 , a P1E6 were1 V 5 2
obtained from Gibco LifeTechnologies. Mouse to
 .human integrin b SZ.21 was obtained from Im-3
munotech. Monoclonal antibody to phosphorylated
 .tyrosine residues 4G10 , polyclonal rabbit antibodies
to FAK, anti-mouse and anti-rabbit antibodies conju-
gated to horseradish peroxidase, rabbit serum, and
protein A sepharose beads were from UBI Lake
. Placid, NY , Santa Cruz Biotechnology Santa Crux,
.  .CA , Amersham Canada Oakville, ON , Cedarlane
 . Hornby, ON, Canada , and Pharmacia Uppsala,
.Sweden , respectively. Calcein-AM was purchased
 .from Molecular Probes Eugene, OR . BPD-MA was
provided by QLT PhotoTherapeutics as a lyophilized
powder of a liposomal formulation. Aliquots were
reconstituted with distilled water to a concentration
of 2 mgrml and stored protected from light at 48C for
no longer than two weeks.
2.3. Photodynamic treatment
18 to 24 h after having been replenished with fresh
medium, HFF were harvested following a short expo-
sure to trypsin–EDTA at room temperature. Trypsin
 .inhibitor final concentration 1 mgrml was added to
the cell suspension before cells were spun, washed
with PBS, and spun again. Cells were eventually
resuspended in DMEM containing 0.2% BSA and
 .25mgrml cycloheximide DBC and mixed with dif-
ferent dilutions of BPD-MA into polypropylene tubes
for 1 h in the dark at 378C in a humidified 5% CO2
atmosphere. HFF were washed twice with PBS and
resuspended in DBC before being exposed to 1 Jrcm2
of red light. The light source was a custom-made
light box consisting of two banks of eight 15 W red
 .fluorescent tubes F15T8-R, General Electric, USA
illuminating the exposure chamber from top and bot-
tom. The fluence rate was 3 mWrcm2 as measured
 .by an IL 1400A Photometer International Light and
corrected for polypropylene transmission. Upon irra-
diation, cells were processed as per one of the follow-
ing protocols.
2.4. Cell adhesion assay
Immulon2 96 well plates Dynatech Laboratories,
.Chantilly, VA were coated overnight with COL
 .  .  .5 mgrwell , FN 1 mgrwell , VN 0.2 mgrwell , or
 .BSA 200 mgrwell at room temperature under ster-
ile conditions. Wells were washed with PBS, and
nonspecific binding sites were blocked with 100 ml of
0.2% BSA in DMEM for 90 min at 378C. Wells were
seeded with 100 ml of the appropriate cell suspension
at 3 to 5=104 cellsrml. The plate was then incu-
bated in a humidified 5% CO chamber at 378C for2
45 min. Nonadherent cells were removed by centrifu-
 .gating the plate, top side down, at 200 rpm f50=g
for 5 min. The attached cells were fixed with methanol
for 10 min at room temperature. Methanol was dis-
carded and the plate dried. Cells were stained with
1% crystal violet in 70% ethanol in water for 20 min
at room temperature. The plates were thoroughly
washed with tap-water and dried. Crystal violet was
extracted with 1% SDS in water. The optical density
of the plates was read at 590 nm in a microplate
 .reader Dynatech, USA and corrected for back-
ground measured at 405 nm. Each experiment was
run in triplicate.
2.5. Cell sur˝i˝al
Following treatment, 100 ml of cell suspension
 4 .2.5 to 5=10 cells was poured into a 96 well tissue
 .culture plate Falcon, USA to which 100 ml 20%
FBS in DMEM was added final FBS dilution is
.10% . After an overnight incubation at 378C, 5%
CO , the MTT assay was carried out as described by2
w xRichter et al. 21 .
2.6. Flow cytometry
Integrins were labelled for flow cytometric analy-
sis by indirect immunofluorescence. 30 min following
light treatment, cells were washed twice and resus-
pended in PBS buffer containing 1% BSA and 0.2%
 .sodium azide PBS-azide for 30 min before primary
antibodies to integrins were added. Following an hour
incubation on ice, cells were washed twice with
PBS-azide and stained with phycoerythrin-conjugated
 X.F ab fragment of rabbit antibody to mouse IgG2
 .Serotec, UK for another hour on ice. Cells were
washed twice with PBS before fixation with 2%
paraformaldehyde. Cells were analysed with an
w EPICS XL flow cytometry system Coulter Corp.,
.Miami, FL equipped with an Argon laser. The exci-
tation wavelength was 488 nm while a 575 nm long-
pass emission filter was used to detect phycoerythrin
( )P. Margaron et al.rBiochimica et Biophysica Acta 1359 1997 200–210 203
fluorescence. To reduce the effects of nonspecific
binding, gates were drawn based on cell samples
labelled with the mouse IgG1 isotypic control.
10,000 cells were analysed for each histogram.
( )2.7. Lactate dehydrogenase LDH assay
Release of LDH was measured by the Cytotox96e
 .assay Promega, Madison, WI . This assay is based
on the enzymatic conversion of a tetrazolium salt into
a formazan product by LDH released from cells and
diaphorase present in the substrate mixture. Briefly,
45 min following deposition of 50 000 cells on coated
 .wells see section above , 50 ml medium was mixed
to 50 ml assay substrate mixture for 30 min, and
formazan concentration was determined by measur-
ing optical absorbance at 490 nm in a 96 well plate
 .Dynatech reader, USA . Phenol red-free medium
was used for this assay to eliminate optical interfer-
ence between phenol red and the red formazan prod-
uct. Maximal LDH release was determined by lysing
cells with 0.5% Triton X-100 solution in PBS.
2.8. Propridium iodidercalcein AM assay
 .50 ml of calcein AM 1.6 mgrml and PI
 .10 mgrml in PBS was freshly prepared and added
to HFF in 50 ml phenol red-free at the completion of
the 45 min adhesion. Cells were returned to the incu-
bator for 20 min. In order to decrease the fluores-
cence background, 50 ml of supernatant was carefully
removed and replaced with 50 ml PBS before plates
were observed and photographed using a fluores-
cence microscope. The lipophilic calcein AM is
cleaved only in viable cells into a green fluorescent
membrane-impermeable product whereas the DNA-
probe propidium cation penetrates the compromised
w xmembranes of dead cells 22 .
2.9. Western immunoblotting
For signal transduction experiments, 10 cm diame-
ter untreated Petri dishes VWR, Toronto, ON,
.Canada were coated overnight with COL
 .  .100 mgrdish or FN 86 mgrdish at room tempera-
ture under sterile conditions and processed as de-
scribed above for Immulon2 plates, except that dishes
were seeded with 106 cells. After a 45 min incubation
at 378C, 5% CO , the supernatant, containing non2
adhering cells, was carefully collected. The adherent
cells were washed with PBS, and the washing solu-
tion was added to the supernatant, which was spun at
500 rpm for 5 min. The pellet was lysed in cold lysis
buffer consisting of Tris–buffered saline 137 mM
.NaCl, 20 mM Tris–HCl, pH 7.8 containing 1% Non-
idet P-40, 10% glycerol, 1 mM phenylmethyl-
sulfonylfluoride, 0.15 Urml aprotinin, and 1 mM
sodium orthovanadate on ice for 1 h. Adherent cells
were aslo lysed in this cold lysis buffer. Lysates of
adherent and suspended cells were grouped, and in-
soluble material was removed by centrifugation at
14,000 rpm for 15 min at 48C. The protein content of
the lysates was determined with a BCA kit Pierce,
.Rockford, IL using BSA as a standard. The lysates
were heated at 958C for 5 min in a sample buffer
 .containing 62 mM Tris–HCl pH 8 , 2% SDS, 10%
glycerol, and 5% 2-mercaptoethanol. The released
proteins were separated by 7.5% SDS-polyacrylamide
 .gel electrophoresis SDS-PAGE and electrophoreti-
cally transferred onto a nitrocellulose membrane for
3–4 h at 70 V in a cooling tank. After washing the
membrane twice with 0.1% Tween in PBS PBS-
.Tween , nonspecfic binding sites on the membrane
were blocked with 5% skim milk in PBS for 30 min
at room temperature. The membrane was then probed
with monoclonal antibody to phosphotyrosine dilu-
.tion 1:1000, 2 h incubation at 208C or polyclonal
antibody to FAK dilution 1r100, 45 min incubation
.at 208C in 5% skim milk, washed twice with PBS-
Tween. The membrane was then incubated with the
appropriate secondary antibody conjugated to horse-
 .radish peroxidase dilution 1r3000 for 30 min to 1 h.
The blot was washed as above, and biotinylated
molecular weight standards were probed with strepta-
vidin-horse radish peroxidase conjugate 1:5000 in
.PBS-Tween for 30 min. After washing, the mem-
branes were developed using enhanced chemilumi-
 .nescence Amersham according to the manufacturer’s
protocol.
2.10. FAK immunoprecipitation
 .Cell lysates f750 mg protein were precleared
with normal rabbit serum at 1:100 and protein A
 .sepharose beads 1:25 for 1 h at 48C. Lysates were
 .centrifuged 30 s, 14 000 rpm , and supernatants were
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immunoprecipited overnight with polyclonal anti-
FAK at a dilution of 1:50 at 48C. Protein A sepharose
 .beads 1:10 were added for 2 h at 48C. Beads were
then washed 3 times with lysis buffer before being
resuspended in sample buffer. FAK immunoprecipi-
tates were then processed for Western blotting as
described above.
3. Results
3.1. Integrin profile
To identify the integrins involved in HFF adhesion
on the three matrices studied, blocking antibodies to
various integrins were incubated with the HFF before
and during the adhesion assay. Cells were pretreated
with the translation-inhibitor cycloheximide to pre-
vent de novo synthesis of ECM molecules; they were
also maintained in serum-free medium to eliminate
potential effects from soluble serum matrix and ex-
ogenous stimulants. Cells did not adhere to wells
coated with BSA. It appeared that the integrin profile
 .was distinctive for each matrix Table 1 . Anti-b1
integrin antibody almost totally abrogated binding of
HFF to COL whereas it had an insignificant effect on
HFF binding to VN or FN. Furthermore, the integrin
a b appeared to mediate HFF adherence to VNV 5
only, and an antibody to a inhibited HFF adhesion5
to FN, but not to COL. These results were in agree-
Table 1
Inhibition of HFF adhesion on ECM by monoclonal antibodies to
integrins
Clone Integrin Fibronectin Collagen type I Vitronectin
specificity
P1E6 a y qq y2
B-5G10 a qq ND ND4
mAb 16 a qqq y ND5
P1F6 a b q y qqqqV 5
P4C10 b qq qqq q1
SZ 21 b y q q3
Antibodies were added to the cell suspension for 30 min at 48C.
Cells were seeded into coated wells for 45 min at 378C in a
humidified, 5% CO chamber and fixed as described in Section2
2. Inhibition of HFF adhesion by antibody is expressed as a % of
isotypic control and scored as follows: qqqqG75%; 75%)
qqqG50%; 50%)qqG25%; 25%)qG5%; y-5%;
ND: not determined.
Fig. 1. HFF cell viability 45 min after PDT as determined by the
 .calcein AMrPI assay. Control cells A, C or cells preincubated
 .  .for 1 h with BPD-MA 100ngrml in the dark B, D were
irradiated with 1 Jrcm2 red light while in suspension. Cells were
 .  .then left on COL A, B or FN C, D for 45 min. Cells were
stained using the calcein AMrPI solution as described in Section
2.
ment with those obtained by different groups using
w xvarious types of cells 17 .
3.2. Inhibition of cell adhesion
The capacity of fibroblasts to adhere to three
different extracellular matrices within 45 min was
evaluated using a colorimetric assay. This time period
  .sufficed to cell adhesion and spreading Fig. 1 A ,
 ..C .
BPD-MA in the concentration range assessed or
1 Jrcm2 red light alone did not affect cell adhesion
 .on any matrix data not shown . Conversely, the
combination of light and photosensitizer inhibited
fibroblast adhesion in a dose-dependent manner Fig.
.2 . The concentrations of BPD-MA inhibiting adhe-
sion on COL, FN, and VN by 50% were 46, 74, and
91 ngrml, respectively. However, differences among
the attachment of HFF to the matrices were not
statistically significant for any tested concentration,
and the three dose-response curves coincided. Inhibi-
tion was maximal at a dose of 100 ngrml. At this
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Fig. 2. Dose-dependent, but matrix-independent PDT-induced
inhibition of HFF adhesion. Cells in suspension were incubated
with BPD-MA for 1 h in the dark and irradiated with 1 Jrcm2 red
light. Cells were then placed in wells coated with bovine COL
 .  .  .X , FN ‘ , and VN B for 45 min before fixation and
staining. Results are expressed as % of adhesion of cells exposed
to light alone and are the mean of 3 to 6 experiments; error bars
represent S.E.
drug dose, cells were still round 45 min after the light
  .  ..treatment Fig. 1 B , D , although 32 to 45% were
capable of adhering to ECM at that time. However,
the BPD-MA concentration of 100 ngrml provoked a
90% cell death within 20 h following the treatment as
 .measured by the MTT assay Fig. 3 . The cell sur-
vival response was steeper than the adhesion profile,
Fig. 3. Cell survival following PDT as a function of BPD-MA
concentration. HFF in suspension were incubated with BPD-MA
 .for 1 h in the dark only I or subsequently irradiated with
2  .1 Jrcm red light B . Cells were seeded into 96-well tissue
culture plate overnight before cell viability was measured using
the MTT assay. Results are expressed as % of untreated control
and are the mean of 3 to 6 experiments; error bars represent S.E.
Fig. 4. Influence of PDT on LDH release. HFF in suspension
2  .were exposed to 1 Jrcm red light B or incubated with BPD-
 .  .MA 100ngrml for 1 h and exposed to red light I . Cells were
 .then seeded in tissue culture uncoated or matrix-coated 96-well
plates for 45 min. Medium was collected and assessed for LDH
activity. Results are expressed as % of activity obtained when
complete lysis of cells was performed. Results are the mean of 2
experiments; error bars represent S.D.
suggesting that early loss of adhesiveness was not a
prerequisite for PDT-induced cell kill.
3.3. Membrane integrity and cell ˝iability
Seeing that the inhibition of fibroblast adhesion
was maximal at 100 ngrml, the subsequent experi-
ments were carried out with this concentration. Al-
though it ultimately resulted in 90% cell death, mem-
brane integrity was not initially impaired as illus-
Fig. 5. PDT does not alter HFF integrin expression levels. One
hour following exposure to 1 Jrcm2 red light, cells were
surface-labelled for integrin and processed for flow cytometry.
Results are expressed as the ratio of the mean fluorescence
 .intensities of cells treated with BPD-MA 100ngrml and light
and cells which received light only. Results are the mean of 2
experiments; error bars represent S.D.
( )P. Margaron et al.rBiochimica et Biophysica Acta 1359 1997 200–210206
trated by the LDH and calceinrPI dye exclusion
assays. LDH is a cytoplasmic enzyme, and its pres-
ence in culture medium signifies that the plasma
membrane has been damaged. In supernatants from
cells seeded for 45 min on ECM following PDT, the
level of LDH activity was not significantly different
from that of supernants from cells treated with light
 .only Fig. 4 . In addition, PDT-treated cells retained
calcein, a fluorescent marker of cell viability Fig.
 .  .. 1 B , D , to the same extent as control cells Fig.
 .  ..1 A , C . Accordingly, few cells treated with either
light alone or BPD-MA and light took up propidium
ion, a DNA stain that penetrates only non-viable
cells.
 .Fig. 6. PDT affects adhesion-induced phosphorylation of FAK. A Immunoblots of phosphotyrosine-containing proteins in lysates from
 .  . 2  .  .  .light only treated cells y or cells treated with BPD-MA 100 ngrml and 1 Jrcm q collected 1 before PDT, 2 immediately
 .  .following PDT, or after 3 a 45 min or 4 overnight incubation in FN-coated wells. The molecular weights of marker proteins are
 .  .indicated in kilodaltons. B Aliquots of the same lysates were subjected to immunoblotting with anti-FAK. C Lysates from cells
2  .  . 2  .exposed to 1 Jrcm red-light alone 2, 4 or treated with BPD-MA 100 ngrml and 1 Jrcm red-light 3, 5 and incubated 45 min on
 .  .COL 1, 2, 3 or FN 4, 5 after PDT were immunoprecipitated with an antibody to FAK. The immunoprecipitates were subjected to
SDS-PAGE followed by immunoblotting with anti-phosphotyrosine antibody. No anti-FAK was added to control cell lysate during the
 .  .immunoprecipitation 1 . D Aliquots of the same immunoprecipitates were subjected to immunoblotting with anti-FAK.
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3.4. Integrin expression
To assess the expression and functionality of inte-
grins after PDT, cells were labelled with blocking
antibodies to integrins within a time frame corre-
sponding to that of the adhesion assay. BPD-MA,
 .light alone data not shown , or PDT did not affect
 .the intensity of integrin staining Fig. 5 . This sug-
gested that PDT did not affect integrin expression,
but also that the ligand-binding epitope was not
photodamaged.
3.5. PTK acti˝ity
The impact of PDT on cytoplasmic signal trans-
duction was then investigated. Lysates from cells
treated with PDT or light only were collected either
before irradiation, just after the light treatment, or
following a 45 min or overnight adhesion on COL or
FN. SDS-PAGE of lysates was followed by gel im-
munoblotting with the monoclonal antibody 4G10 to
phosphorylated tyrosine residues. No difference was
apparent in the phosphorylation pattern between
BPD-MA-loaded and control cells before and imme-
  .diately after the light treatment Fig. 6 A , lanes 1
.and 2 . In contrast, a band corresponding to a 120–
130 kDa molecular weight protein was present exclu-
sively in the lane of the control sample collected at
the completion of the 45 min adhesion assay, as
  . .opposed to that treated by PDT Fig. 6 A , lanes 3 .
This band was also the most intense for the overnight
control sample; it was slightly expressed in the treated
sample collected after an overnight incubation Fig.
 . .6 A , lanes 4 . In addition, control cells cultured
overnight expressed several bands – including a
smeared pattern corresponding to molecular weights
ranging from 70 to 150 kDa – which appeared less
distinctly in treated samples. Thus, PDT either de-
pleted the cell of a 120–130 kDa protein or inhibited
the adhesion-induced phosphorylation of such a pro-
tein. The tyrosine kinase FAK is an obvious candi-
date for this 125 kDa protein: it is known to localize
to focal contacts, and its autophosphorylation coin-
cides with matrix binding to integrins at focal adhe-
w xsions 23 . As determined by immunoblotting a simi-
lar gel with a polyclonal antibody to FAK, FAK
expression was not downregulated by PDT Fig.
 ..6 B , strongly suggesting that PDT might affect
FAK’s adhesion-induced phosphorylation.
To verify this hypothesis, cell lysates were im-
munoprecipitated with a polyclonal antibody to FAK,
and the precipitate was immunoblotted with 4G10
  ..Fig. 6 C . As expected, the kinase was not phos-
phorylated immediately after light treatment of cells
maintained in suspension for more than an hour data
.not shown . However, control cells expressed phos-
phorylated FAK at the end of the adhesion assay,
while FAK from PDT-treated cells was not phospho-
rylated. Probing a blot of the same aliquots for FAK
allowed us to confirm that the previous observations
were not the consequence of FAK degradation or its
  ..down-regulation Fig. 6 D . Therefore, PDT ap-
peared to inhibit the adhesion-induced phosphoryla-
tion of FAK.
4. Discussion
This study describes the effects of PDT on cell
adhesion. Using blocking monoclonal antibodies to
various a and b integrins in the adhesion assay, we
first ensured that adhesion of HFF to COL, FN, or
VN was integrin-mediated. In addition, each ECM
glycoprotein was recognized by a specific set of
w xintegrins conforming to previous observations 17,24 .
Albeit a receptor for multiple extracellular glyco-
proteins, the integrin b was weakly involved in our3
system. Accordingly, a b – a predominant form ofV 3
b integrin in mesenchymal cells – mediated cell3
w xmigration rather than cell spreading 25 . The integrin
a , in association with b , was a receptor for COL2 1
w xonly, whereas a was specific to FN 25 . The5
promiscuous b coupled to a or a promoted1 V 1
w xadhesion of smooth muscle cells to FN and VN 25 .
Yet, the anti-b P4C10 did not substantially inhibit1
HFF adhesion to these matrices. Finally a b boundV 5
w xto VN only, as shown with various cell lines 26–28 .
PDT inhibited cell adhesion in a dose-dependent
manner. However, the BPD-MA concentration that
killed 90% of cells within 20 h post-PDT evoked a
substantial but incomplete suppression of HFF adher-
ence to ECM, though PDT-treated cells did not
spread. This suggested a moderate but irrevocable
early alteration in cell properties after PDT. Accord-
ingly, at the completion of the adhesion assay, mem-
branes of PDT-treated HFF were impervious to the
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influx of propidium iodide or the egress of both LDH
and calcein. Yet, cell membranes can be a primary
w xtarget of PDT 29–31 , and their perforation – a
consequence of the oxidative damage of intrinsic
membrane proteins or lipid peroxidation – can lead
w xto the osmotic lysis of the cell 29,30 . However,
doses of light and photosensitizer required to lyse
w xmelanoma cells were at least 1 log higher 31 than
those we utilized. We, therefore, assumed that, under
the present experimental settings, PDT-related abate-
ment of HFF adhesiveness did not implicate any
immediate loss of cell viability and membrane alter-
ation. That BPD-MA does not associate with the
plasma membrane but accumulates in a perinuclear
region of the cell H. Meadows, S Leong, and P.
.Margaron, unpublished data strongly supports this
hypothesis.
The abolition of HFF adhesiveness could have
been caused by integrin endocytosis, an event associ-
w xated with cell migration 32,33 or differentiation
w x34 . Nonetheless, no rule seems to prevail regarding
the effects of oxidative stresses, caused by either UV
irradiation or direct exposure to reactive oxygen
species, on integrin expression. Although cell surface
proteins involved in antigen-presenting function were
down-regulated, UVB-irradiation of human mono-
w xcytes, Epstein-Barr virus-transformed B cells 35 ,
w xand murine epidermal dendritic cells 36 did not
affect integrin a b cell surface level. However,L 2
expressions of a b and a b integrins by ConL 2 4 1
A-stimulated human peripheral blood mononuclear
cells were decreased after UVA treatment in the
w xpresence of 8-methoxypsoralen 37 . Oxidant-stressed
w x w xneuronal 38 or kidney epithelial cell line 39 lost
adhesiveness to ECM, whereas subjecting human
polymorphonuclear cells to external oxidants upregu-
lated the cell surface level of b integrins and aug-2
mented the leukocyte adhesion to endothelial cell
w x40 . We presently report that PDT-treated cells did
not modulate the expression of integrins under the
prevailing experimental conditions.
We cannot, however, rule out a possible inhibition
of integrin activation since the antibodies utilized in
this study were not specific to the high binding
 .affinity or activation state of integrins. Activation of
various integrins is required to initiate or facilitate the
w xtransition of cells from suspension to adherence 41 .
The conformational change of their external domain,
w xmediated by the integrin cytoplasmic domain 42 ,
allows the integrins to bind to their ligand with high
affinity without modifying the overall cell surface
expression. Nonetheless, one could conclude that
PDT-dependent suppression of HFF adhesion was
unrelated to integrin degradation. This assumption is
supported by the fact that the adhesion inhibition was
similar for the three matrices, whereas the integrins
involved in HFF adhesion to each of these ECM were
distinct. It is therefore appealing to propose that PDT
could have suppressed integrin-mediated adhesion by
altering a denominator common to the different inte-
grins – a series of molecules essential to the integrin
function or directly participating in, or ancillary to,
the integrin signalling pathway – rather than directly
modifying each particular integrin.
Whereas the integrin extracellular domain and the
membrane integrity were not affected, PDT exten-
sively inhibited cell spreading and prevented cells
from recovering their spindle shape. Accordingly,
PDT induced morphological changes of tumor cells
w x w x5 and swelling of endothelial cells 43 . Such
changes were also reported during the course of
w xPDT-induced apoptosis 7 . In addition, rounding of
w xendothelial cells 44 , fibroblasts, and keratinocytes
w x45 paralleled F-actin disappearance. Interestingly,
BPD-MA evoked an apoptotic response following
w xlight irradiation 46 , including the activation of the
protease cascade chain. Since interleukin 1b-convert-
w xing enzyme cleaves globular actin 47 as part of the
apoptotic process, it is tempting to hypothesize that
PDT may irreversibly damage the actin cytoskeleton,
thereby preventing cell from regaining their spindle
shape.
Integrin-mediated cell adhesion is accompanied by
phosphorylation of various proteins including the
cytoskeletal protein paxillin, tyrosine kinases e.g.
. FAK , or serine–threonine kinases e.g. protein ki-
. w xnase C, mitogen-activated protein kinases 19 . We
specifically noted the phosphorylation on tyrosine
residues of several proteins associated with spreading
untreated fibroblasts. In contrast, a lower level of
tyrosine phosphorylation was detected in PDT-treated
cells. In particular, the adhesion of fibroblasts to
ECM rapidly induced the phosphorylation of a
;125 kDa protein, which was inhibited by PDT.
Indeed, immunoprecipitation studies suggested that
PDT suppressed the adhesion-induced phosphoryla-
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tion of FAK. FAK is a tyrosine kinase participating
w xin integrin signalling 19,23 . Localized in focal adhe-
sions, it autophosphorylates upon ligand-integrin
binding and integrin clustering; it is also activated by
pp60src. In as much as integrin cytoplasmic segments
lack catalytic domains, FAK is believed to be re-
cruited by integrins upon activation to evoke intra-
cellular responses including actin cytoskeleton rear-
rangement and the activation of transcription factors
w x48 . A modification of membrane fluidity or protein
bilayer mobility caused by PDT-induced protein
w xcrosslinks and lipid peroxidation 2,3 might have
affected integrin clustering and eventuated in the
inhibition of FAK phosphorylation. Although PDT
did not appear to have altered the extracellular por-
tion of integrins, it might have disrupted the link
between integrins and FAK andror the cortical ar-
rangement of cytoskeletal proteins and PTKs, which
could similarly have affected receptor clustering and
resulted in the repression of FAK activation. Also, an
intact cytoskeleton seems necessary for the induction
w xof FAK phosphorylation 23 , but, as suggested above,
PDT might have irrevocably altered the actin cyto-
skeleton. On the other hand, PDT might activate
p50csk, a PTK localized in focal adhesions, of which
w xoverexpression leads to cell rounding 49 and in-
sulin-induced dephosphorylation of FAK and paxillin
w x50 , possibly through the down-regulation of the
kinase activity of src family PTKs. Still, whichever
mechanism is involved, the effect of PDT on integrin
signalling is demonstrated by the inhibition of FAK
phosphorylation.
Although our efforts were focused on FAK, p130cas
is another PTK of similar molecular weight involved
w xin cell adhesion 51,52 , of which activity could be
affected by PDT. Also, this work did not envisage the
effects of PDT on other cell surface adhesive
molecules, including the proteoglycan syndecans,
which were recently found to play a role in cellrma-
w xtrix adhesion 53 .
We herein reported that the ability of fibroblasts to
adhere to extracellular matrices was suppressed by
PDT. Our results suggest that PDT likely interferes
with integrin-mediated cell adhesion and integrin sig-
nalling without altering integrin cell surface expres-
sion or membrane integrity. These observations en-
gender more specific questions about the mechanisms
by which PDT affects focal adhesions. Better under-
standing of these aspects may help us find the appro-
priate tools for modulating cell adhesion and migra-
tion and tackle disorders such as autoimmune dis-
eases, cancer metastasis, or restenosis.
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